press releases

►2024
- April
- March
- February
- January
►2023
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
►2022
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
►2021
- December
- November
- October
- September
- July
- June
- May
- April
- February
- January
►2020
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
►2019
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
►2018
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
►2017
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
►2016
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
►2015
- December
- November
- October
- September
- August
- July
- May
- April
- March
- February
- January
►2014
- December
- November
- October
- September
- August
- July
- June
- May
- April
- February
- January
►2013
- December
- November
- August
- July
- May
- January
►2012
- November
- August
- May
- January
►2011
- December
- November
- October
- August
- April
- March
►2010
- October
- June
►2009
- September
►2008
- November
►2007
- March

February 22, 2024

Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Full year 2023 net revenues of $509 million and fourth quarter net revenues of $134 million PMA application for TTFields in NSCLC accepted for review by U.S. Food and Drug Administration Enrollment completed in phase 3 TRIDENT trial studying the use of TTFields therapy and concomitant radiation for the treatment… Read More

learn more